For the interim period of the fiscal year ending March 2027, net sales were 50,189 million yen, up 6.2% year-over-year. Operating income was 3,639 million yen, down 11.1% year-over-year; ordinary income was 4,209 million yen, down 3.7%; and interim net income attributable to owners of parent was 3,192 million yen, down 5.0%. The full-year dividend forecast is 118 yen (interim dividend at the end of Q2: 55 yen; the full-year forecast includes an increase of 63 yen). Treasury stock at the end of the interim period amounted to 5,903 thousand shares (impact from capital policy due to increase in treasury stock).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4526","jir_company_name":"Riken Vitamin Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4526-20261112-01.pdf","jir_short_summary":"For the interim period of the fiscal year ending March 2027, net sales were 50,189 million yen, up 6.2% year-over-year. Operating income was 3,639 million yen, down 11.1% year-over-year; ordinary income was 4,209 million yen, down 3.7%; and interim net income attributable to owners of parent was 3,192 million yen, down 5.0%. The full-year dividend forecast is 118 yen (interim dividend at the end of Q2: 55 yen; the full-year forecast includes an increase of 63 yen). Treasury stock at the end of the interim period amounted to 5,903 thousand shares (impact from capital policy due to increase in treasury stock).","jir_summary":"### Overview of Results\nRiken Vitamin recorded interim net sales of 50,189 million yen, an increase of 6.2% compared with the same period last year. However, operating income decreased to 3,639 million yen, a decline of 11.1% year-over-year. Ordinary income was 4,209 million yen, and interim net income attributable to owners of parent was 3,192 million yen, a decrease of approximately 5% year-over-year. By segment, domestic food, domestic chemical products and overseas businesses all posted sales growth, but profits were pressured by higher raw material and labor costs and a revised estimate for asbestos removal expenses. Holdings of treasury stock increased, and the equity ratio rose to 72.6%.\n\n### Outlook and Dividend Policy\nEarnings forecasts for the fiscal year ending March 2027 have been revised and a change to the dividend policy has been announced. Shares outstanding at fiscal year-end are 30,705,100 shares, treasury stock at fiscal year-end is 2,140,919 shares, and the average number of shares during the period is 28,920,719 shares. The latest dividend forecast is 118 yen for the full fiscal year ending March 2027 (interim dividend at the end of Q2: 55 yen; the full-year forecast includes a 63 yen dividend increase). Taking into account domestic and international market conditions, Riken Vitamin will monitor factors such as rising raw material costs, foreign exchange trends and asbestos removal expenses, while promoting a medium-term plan aimed at sustainable growth.","jir_financial_highlights":"Net Sales: 50,189 million yen (YoY +6.2%)\nOperating Income: 3,639 million yen (YoY -11.1%)\nOrdinary Income: 4,209 million yen (YoY -3.7%)\nNet Income Attributable to Owners of Parent (Interim): 3,192 million yen (YoY -5.0%)\nTreasury Stock: 5,903 thousand shares (Increased from previous interim period)\nEquity Ratio: 72.6% (Increased from previous fiscal year)","jir_category":"","jir_hashtags":"#RikenVitamin, #InterimResults, #FinancialHighlights","jir_key_figures":"Net Sales: 50,189 million yen (YoY +6.2%)\nOperating Income: 3,639 million yen (YoY -11.1%)\nNet Income Attributable to Owners of Parent (Interim): 3,192 million yen (YoY -5.0%)","jir_meta_title":"Riken Vitamin Co., Ltd. \u2014 FY2027 Q2 Interim Results | Sales Up but Profits Down","jir_meta_description":"Key points from Riken Vitamin Co., Ltd.'s FY2027 Q2 interim results: net sales 50,189 million yen, operating income 3,639 million yen, net income 3,192 million yen. Full-year dividend forecast 118 yen. Analysis of treasury stock movement and outlook.","jir_og_title":"Analysis of Riken Vitamin Co., Ltd.'s Q2 Interim Results | Sales Increased, Profits Declined","jir_og_description":"Summary of Riken Vitamin Co., Ltd.'s interim results. Net sales rose year-over-year, while operating income and net income declined. Full-year dividend forecast is 118 yen. Watch treasury stock developments.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16690,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-150788","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n